コンテンツへスキップ
Merck

L7875

DL-Leucine

≥99% (HPLC)

別名:

(±)-Amino-4-methylpentanoic acid

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

化学式:
(CH3)2CHCH2CH(NH2)CO2H
CAS番号:
分子量:
131.17
NACRES:
NA.26
PubChem Substance ID:
UNSPSC Code:
12352209
EC Number:
206-328-2
MDL number:
Beilstein/REAXYS Number:
636005
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

DL-Leucine, ≥99% (HPLC)

Quality Level

assay

≥99% (HPLC)

form

powder

color

white

mp

293-296 °C (subl.) (lit.)

solubility

1 M HCl: soluble

application(s)

detection
peptide synthesis

SMILES string

CC(C)CC(N)C(O)=O

InChI

1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)

InChI key

ROHFNLRQFUQHCH-UHFFFAOYSA-N

Application

DL-Leucine is a racemic mixture of the D- and L- enantiomers of Leucine. DL-Leucine is used to form benzimidazole and pyrimidine hydroxy azo dyes with various transition metals. DL-Leucine may be used for the evaluation of chiral amino acid separation techniques.

DL-Leucine is used for the following applications:
  • Used as a standard for the measurement of free amino acids
  • Used in the process of tritiated leucine uptake
  • Used in solution preparation (various organics were used in different combinations and concentrations to model complex surface tension effects, DL-Leucine is one of them). It is chosen due to its presence in atmospheric aerosols and ice nucleation activity as well as for its surfactant character


Still not finding the right product?

Explore all of our products under


保管分類

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



H Chang et al.
British journal of haematology, 111(1), 146-156 (2000-11-25)
Transfusion-associated graft-versus-host disease (TA-GVHD) is usually a fatal outcome of blood transfusion therapy, caused by viable leucocytes contained in the donor blood. Most cases of TA-GVHD occur when less than 4-d-old blood is transfused. We therefore examined the molecular changes
L Sallami et al.
Journal of dairy science, 87(6), 1585-1594 (2004-09-30)
The effect of incorporating a highly autolytic strain (Lactobacillus delbrueckii subsp. bulgaricus UL12) a proteolytic strain (Lactobacillus casei subsp. casei L2A), or a nisin Z-producing strain (Lactococcus lactis, subsp. lactis biovar diacetylactis UL719) into Cheddar cheese starter culture (Lactococcus lactis
Modeling the surface tension of complex, reactive organic-inorganic mixtures.
A. N. Schwier et al.
Atmospheric Chemistry and Physics, 13, 10721-10732 (2013)